CAS RN: 33901-20-1
N-benzyl-4-hydroxybenzamide
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250331
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 33901-20-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
33901-20-1 / N-benzyl-4-hydroxybenzamide
Standard CAS: 33901-20-1
Multi CAS: No
Basic Information
copy
CAS
33901-20-1 copy
Multi CAS
No copy
Molecular Formula
C14H13NO2 copy
Molecular Weight
227.260000 copy
Exact Mass
227.094629 copy
InChI
InChI=1S/C14H13NO2/c16-13-8-6-12(7-9-13)14(17)15-10-11-4-2-1-3-5-11/h1-9,16H,10H2,(H,15,17) copy
InChIKey
FVQDRWUYZFPHLU-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.07 copy
Rotatable bonds
3 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
65.72 copy
TPSA
49.33 copy
LogP / Solubility
WLOGP
2.32 copy
MLOGP
2.05 copy
XLogP3
1.9 copy
Consensus LogP
2.09 copy
Log S (ESOL)
-3.04 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.1 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.42 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.46 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy